According to a new report, Europe Small Animal Imaging (In-Vivo) Market, published by KBV Research, the Europe Small Animal Imaging (In-vivo) Market is expected to grow at a CAGR of 9.1% during 2016 -2022. The Optical Imaging market dominated the Europe Small Animal Imaging (In-vivo) Market in 2015, and would grow at a CAGR of 6.3% during the forecast period.
The Micro-MRI market is expected attain a market size of $248.2 million by 2022.The Bio-distribution market continued the larger revenue share to the Europe Small Animal Imaging (In-vivo) Market in 2015, and is expected to grow at a CAGR of 8.6% during the forecast period. However, Cancer cell detection market is expected to grow at CAGR of 12.1% during 2016-2022.
The Germany market registered the largest revenue share in the Europe Small Animal Imaging (In-vivo) Market in 2015. The UK market is expected to attain a market size of $191.9 million by 2022. However, France market is expected to grow at CAGR of 9.9% during 2016-2022. The report highlights the adoption of Small Animal Imaging (In-vivo) Market in Europe.Based on the Technology, the Europe Small Animal Imaging (In-vivo) Market is segmented into Micro-MRI, Optical Imaging, Nuclear Imaging and Others (Micro-Ultrasound and micro-CT) segment.
Based on the Application, the market is bifurcated into Monitoring treatment, Bio-distribution, Cancer cell detection, Biomarkers, Longitudinal studies and Epigeneticssegments. The countries included in the report are Germany, UK, France, Russia, Spain, Italy and Rest of Europe. Key players profiled in the report includes Thermo Fisher Scientific Inc., Mediso Medical Imaging Systems, Promega Corporation, Miltenyi Biotech GmbH, Bruker Corporation, PerkinElmer Inc., Aspect Imaging Ltd., Siemens AG and Fujifilm Holdings Corporation.
Full report : https://www.kbvresearch.com/europe-small-animal-imaging-market
The market is segmented based on Technology, Application and Country.
Related Reports:
Global Small Animal Imaging (In-vivo) Market
North America Small Animal Imaging (In-vivo) Market
Unique Offerings 
